Cell-cycle Checkpoints and Aneuploidy on the Path to Cancer
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
The cell cycle is a complex sequence of events through which a cell duplicates its contents and divides, and involves many regulatory proteins for proper cellular reproduction, including cyclin proteins and cyclin-dependent kinases, oncogenes and tumor-suppressor genes, and mitotic checkpoint proteins. Mutations of any of these regulatory mechanisms can lead to reproduction of cells carrying genetic mutations or abnormal numbers of chromosomes, resulting in genomic instability. Chromosomal instability, contributing to genomic instability, refers to abnormalities in the number of chromosomes, and leads to aneuploidy. The role of aneuploidy in cancer cell development is often disputed, as conflicting hypotheses and research make it unclear as to whether aneuploidy is a cause or consequence of cancer. Here, we present an overview of the importance of cell-cycle checkpoint regulation and chromosomal instability in the development of cancer, and discuss evidence for conflicting arguments for the role of aneuploidy in cancer, leading us to conclude that further investigation of this role would benefit our understanding of cancer development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,961
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
Genetic instability in colorectal cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386623a0 · Cited by 1,986
Mutations of mitotic checkpoint genes in human cancers
Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/32688 · Cited by 1,486
To cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
A mechanism linking extra centrosomes to chromosomal instability
Ganem, N. J., Godinho, S. A., & Pellman, D. (2009) · Nature · doi:10.1038/nature08136 · Cited by 1,422
Causes and consequences of aneuploidy in cancer
Gordon, D. J., Resio, B., & Pellman, D. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3123 · Cited by 815
Rieder, C. L., Cole, R. W., Khodjakov, A., & Sluder, G. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.4.941 · Cited by 713
Schafer, K. A. (1998) · Veterinary Pathology · doi:10.1177/030098589803500601 · Cited by 604
Identification of a Human Mitotic Checkpoint Gene: hsMAD2
Li, Y., & Benezra, R. (1996) · Science · doi:10.1126/science.274.5285.246 · Cited by 598
Weaver, B. A., & Cleveland, D. W. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.10.002 · Cited by 557
The spindle checkpoint, aneuploidy, and cancer
Bharadwaj, R., & Yu, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207374 · Cited by 534
Examining the link between chromosomal instability and aneuploidy in human cells
Thompson, S. L., & Compton, D. A. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200712029 · Cited by 521
Fang, G., Yu, H., & Kirschner, M. W. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80126-4 · Cited by 486
Chromosome segregation and cancer: cutting through the mystery
Jallepalli, P. V., & Lengauer, C. (2001) · Nature Reviews Cancer · doi:10.1038/35101065 · Cited by 463
Splitting the Chromosome: Cutting the Ties That Bind Sister Chromatids
Nasmyth, K., Peters, J.-M., & Uhlmann, F. (2000) · Science · doi:10.1126/science.288.5470.1379 · Cited by 427
Lavigueur, A., Maltby, V, Mock, D., Rossant, J., Pawson, T., & Bernstein, A. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.9.3982 · Cited by 394
Genetic instability of cancer cells is proportional to their degree of aneuploidy
Duesberg, P., Rausch, C., Rasnick, D., & Hehlmann, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13692 · Cited by 376
What is the restriction point?
Zetterberg, A., Larsson, O., & Wiman, K. G. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80067-0 · Cited by 351
The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.
Finlay, C. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.301 · Cited by 311
Zhuang, Z., Park, W.-S., Pack, S., Schmidt, L., Vortmeyer, A. O., Pak, E., Pham, T., Weil, R. J., Candidus, S., Lubensky, I. A., et al. (1998) · Nature Genetics · doi:10.1038/1727 · Cited by 291
Shah, J. V., & Cleveland, D. W. (2000) · Cell · doi:10.1016/s0092-8674(00)00202-6 · Cited by 276
Clarke, A. R., Gledhill, S., Ml, H., Bird, C. C., & Wyllie, A. (1994) · PubMed · Cited by 267
Loss of pRB causes centromere dysfunction and chromosomal instability
Manning, A. L., Longworth, M. S., & Dyson, N. J. (2010) · Genes & Development · doi:10.1101/gad.1917310 · Cited by 240
Darżynkiewicz, Z., Gong, J., Juan, G., Ardelt, B. K., & Traganos, F. (1996) · Cytometry · doi:10.1002/(sici)1097-0320(19960901)25:1<1::aid-cyto1>3.0.co;2-n · Cited by 238
Mechanisms underlying losses of heterozygosity in human colorectal cancers
Thiagalingam, S., Laken, S., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051625398 · Cited by 228
Shichiri, M., Yoshinaga, K., Hisatomi, H., Sugihara, K., & Hirata, Y. (2002) · PubMed · Cited by 177
Cyclins and Cyclin-Dependent Kinases: Theme and Variations
(1995) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60254-7 · Cited by 172
p53 GENE MUTATIONS AND PHOTOCARCINOGENESIS
Nataraj, A. J., Trent, J. C., & Ananthaswamy, H. N. (1995) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1995.tb05262.x · Cited by 168
Yao, S.-L., Akhtar, A. J., Mckenna, K. A., Bedi, G. C., Sidransky, D., Mabry, M. H., Ravi, R. K., Collector, M. I., Jones, R. J., Sharkis, S. J., et al. (1996) · Nature Medicine · doi:10.1038/nm1096-1140 · Cited by 166
Physical and functional interaction between wild-type p53 and mdm2 proteins.
Haines, D. S., Landers, J. E., Engle, L. J., & George, D. L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1171 · Cited by 137
Immunohistochemistry of Cyclin D1 in Human Breast Cancer
Zhang, S.-Y., Caamaño, J., Cooper, F., Guo, X., & Klein–Szanto, A. J. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/102.5.695 · Cited by 120
Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes
Paulsson, K. M., & Johansson, B. (2006) · Pathologie Biologie · doi:10.1016/j.patbio.2006.04.007 · Cited by 109
Ohshima, K., Haraoka, S., Yoshioka, S., Hamasaki, M., FUJIKI, T., Suzumiya, J., Kawasaki, C., Kanda, M., & Kikuchi, M. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00512-7 · Cited by 101
Satyanarayana, A., Berthet, C., Lopez-Molina, J., Coppola, V., Tessarollo, L., & Kaldis, P. (2008) · Development · doi:10.1242/dev.024919 · Cited by 79
Arroyo, M., & Raychaudhuri, P. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.22.5947 · Cited by 65
Beghini, A., Ripamonti, C. B., Castorina, P., Pezzetti, L., Doneda, L., Cairoli, R., Morra, E., & Larizza, L. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00221-6 · Cited by 44
Cited by
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Metadata
- Venue
- In Vivo
- Published
- 2018-01-02
- Volume
- 32
- Issue
- 1
- Pages
- 1-5
- ISSN
- 0258-851X (ISSN-L)
- 1791-7549
- OpenAlex
- W2781175048
- Cited by
- 169
- References
- 39
- FWCI
- 10.07
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.